Colorectal Cancer Immunotherapy Potential Explored Through Hidden Antigens

New research published in Molecular & Cellular Proteomics suggests that treatment-resistant colorectal tumors possess hidden antigens capable of triggering an immune response. This discovery challenges previous assumptions about immunotherapy efficacy in these cancers, potentially opening new avenues for more effective treatment strategies.